A prodrug form of doxorubicin
Related Products
Active Metabolite(s)
15007Doxorubicin (hydrochloride)
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Cholesterol-Doxorubicin

Item No. 9004198

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
(3R,10R,13R,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1R,3R)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)carbamate
Molecular Formula
C55H73NO13
Formula Weight
956.2
Purity
≥95%
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
DMF: 25 mg/mlDMSO: 2 mg/mlEthanol: Slightly soluble
SMILES
O=C(CO)[C@@](C[C@H]1O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](NC(O[C@H]3CC4=CCC(C(CC[C@@H]5[C@@H](CCCC(C)C)C)[C@]5(C)CC6)C6[C@@]4(C)CC3)=O)C2)(O)CC(C1=C7O)=C(O)C8=C7C(C9=C(OC)C=CC=C9C8=O)=O
InChi Code
InChI=1S/C55H73NO13/c1-27(2)10-8-11-28(3)35-16-17-36-32-15-14-30-22-31(18-20-53(30,5)37(32)19-21-54(35,36)6)68-52(64)56-38-23-42(67-29(4)47(38)59)69-40-25-55(65,41(58)26-57)24-34-44(40)51(63)46-45(49(34)61)48(60)33-12-9-13-39(66-7)43(33)50(46)62/h9,12-14,27-29,31-32,35-38,40,42,47,57,59,61,63,65H,8,10-11,15-26H2,1-7H3,(H,56,64)/t28-,29+,31-,32?,35-,36?,37?,38+,40-,42+,47-,53+,54-,55-/m1/s1
InChi Key
XPLIGNAEYPCYSP-MDBLMQNWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $37

    Add

    5 mg

    $136

    Add

    10 mg

    $252

    Add
    Cayman Chemical
    Visit Our Lipid Nanoparticle Resource Center for Additional Tools & Resources
    EXPLORE NOW
    Product Description

    Cholesterol-doxorubicin is a prodrug form of the anticancer agent doxorubicin (DOX; Item No. 15007).1 Cholesterol-doxorubicin, when combined with tocopherol polyethylene glycol succinate/tocofersolan (TPGS; Item No. 34661) in nanoassemblies, reduces MCF-7 and MDA-MB-231 breast cancer cell viability.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Olim, F., Neves, A.R., Vieira, M., et al. Self-assembly of cholesterol-doxorubicin and TPGS into prodrug-based nanoparticles with enhanced cellular uptake and lysosome-dependent pathway in breast cancer cells. Eur. J. Lipid Sci. Technol. 123(5), 2000337 (2021).